| Financial Year |
March 31 2023 |
| Monetary Funds |
5,732,911,646.71 |
| Held-for-trading Financial Assets |
723,690.24 |
| Notes Receivable |
60,300,011.85 |
| Accounts Receivable |
1,360,533,918.48 |
| Advances to Suppliers |
90,025,254.13 |
| Other Receivables |
942,894,701.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,056,102,997.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
60,529,806.63 |
| Total Current Assets |
9,317,118,694.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,428,406,100.61 |
| Investment Properties |
-- |
| Fixed Assetes |
21,497,187,200.29 |
| Under-construction Projects |
134,226,657.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,307,312,613.33 |
| R&D expenses |
73,679,211.21 |
| Goodwill |
732,194,890.21 |
| Long-Term Deferred and Prepaid Expenses |
480,097,267.71 |
| Deferred Income Tax Assets |
1,524,563,321.18 |
| Other Non-Current Assets |
17,068,954.72 |
| Sub-Total of Non-Current Assets |
29,449,341,220.10 |
| Total Assets |
38,766,459,914.84 |
| Short-Term Loans |
6,511,761,814.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
820,925,827.34 |
| Accounts Payable |
4,556,555,925.30 |
| Accounts Received In Advance |
67,796.92 |
| Employee Compensation Payable |
110,069,403.50 |
| Taxes Payable |
6,619,737.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
113,455,292.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,411,109,912.80 |
| Other Current Liabilities |
206,883,207.02 |
| Sub-Total of Current Liabilities |
17,426,296,014.78 |
| Long-term Loans |
2,218,768,858.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,196,416,040.44 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
202,832,496.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,057,480,391.40 |
| Total Liabilities |
24,483,776,406.18 |
| Paid-In Capital(Or Share Stock) |
1,381,486,540.00 |
| Capital Surplus |
13,930,700,898.37 |
| Surplus Reserve |
17,039,690.81 |
| LESS:Treasury Stock |
63,821,196.50 |
| Undistributed Profits |
-4,311,718,949.11 |
| Minority Stockholder's Interest |
3,328,995,905.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,953,687,603.34 |
| Owner's Equity（Stockholder's Equity） |
14,282,683,508.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,766,459,914.84 |
